CORRESP Filing
Lucid Diagnostics Inc.
Date: May 27, 2025 · CIK: 0001799011 · Accession: 0001641172-25-012498
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287496
Letter
Lucid Diagnostics Inc.
Madison Avenue, 25 th Floor
New York, New York 10017
(917) 813-1828
May 27, 2025
VIA EDGAR
Division of Corporation Finance
Office of Industrial Applications and Services
Securities and Exchange Commission
F St. N.E.
Washington, D.C. 20549
Attention: Juan Grana
Re:
Lucid Diagnostics Inc.
Registration Statement on Form S-3
Originally Filed May 22, 2025
File No. 333-287496
Ladies and Gentlemen:
Lucid Diagnostics Inc. (the " Company ") hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 9:30 a.m., Friday, May 30, 2025, or as soon thereafter as practicable.
Very truly yours,
LUCID DIAGNOSTICS INC.
Show Raw Text
CORRESP 1 filename1.htm Lucid Diagnostics Inc. 360 Madison Avenue, 25 th Floor New York, New York 10017 (917) 813-1828 May 27, 2025 VIA EDGAR Division of Corporation Finance Office of Industrial Applications and Services Securities and Exchange Commission 100 F St. N.E. Washington, D.C. 20549 Attention: Juan Grana Re: Lucid Diagnostics Inc. Registration Statement on Form S-3 Originally Filed May 22, 2025 File No. 333-287496 Ladies and Gentlemen: Lucid Diagnostics Inc. (the " Company ") hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 9:30 a.m., Friday, May 30, 2025, or as soon thereafter as practicable. Very truly yours, LUCID DIAGNOSTICS INC. By: /s/ Lishan Aklog, M.D. Name: Lishan Aklog, M.D. Title: Chairman and Chief Executive Officer